ReviewGenes2021

Imprecise Medicine: BRCA2 Variants of Uncertain Significance (VUS), the Challenges and Benefits to Integrate a Functional Assay Workflow with Clinical Decision Rules.

Judit Jimenez-Sainz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.